Infectious mononucleosis prior to acute leukemia: a possible role for the Epstein-Barr virus.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D001215:Asparaginase / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D005455:Fluorescent Antibody Technique; D006168:Guinea Pigs / Q000276:immunology; D004854:Herpesvirus 4, Human; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007244:Infectious Mononucleosis / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D007945:Leukemia, Lymphoid / Q000150:complications / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012756:Sheep / Q000276:immunology; D014750:Vincristine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000914:Antibodies, Viral; D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone; D006854:Hydrocortisone; D008727:Methotrexate